US Stock MarketDetailed Quotes
GENPF GENIX PHARMACEUTICALS CORPORATION
- 0.039000
- 0.0000000.00%
15min DelayClose Apr 17 16:00 ET
2.31MMarket Cap-795P/E (TTM)
0.000000High0.000000Low0Volume0.039000Open0.039000Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)59.22MShares0.25300052wk High-2.60P/B2.31MFloat Cap0.01380052wk Low--Dividend TTM59.22MShs Float0.253000Historical High--Div YieldTTM0.00%Amplitude0.000600Historical Low--Avg Price1Lot Size
GENIX PHARMACEUTICALS CORPORATION Key Stats
Quarterly+Annual
YOY
| (Q1)Jan 31, 2024 | (FY)Oct 31, 2023 | (Q4)Oct 31, 2023 | (Q3)Jul 31, 2023 | (Q2)Apr 30, 2023 | (Q1)Jan 31, 2023 | (FY)Oct 31, 2022 | (Q4)Oct 31, 2022 | (Q3)Jul 31, 2022 | (Q2)Apr 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -95.51%71 | 12.35K | 0 | 2.68K | 8.08K | 1.58K | 0 | 0 | 0 | 0 |
| Operating revenue | -95.51%71 | --12.35K | --0 | --2.68K | --8.08K | --1.58K | --0 | --0 | --0 | --0 |
| Cost of revenue | -98.28%13 | 9.08K | 0 | 433 | 7.89K | 757 | 0 | 0 | 0 | 0 |
| Gross profit | -92.97%58 | 3.26K | 0 | 2.25K | 189 | 825 | 0 | 0 | 0 | 0 |
| Operating expense | -79.20%47.32K | -14.26%884.16K | 16.76%270.3K | -32.98%166.44K | -1.40%219.88K | -30.71%227.54K | -37.69%1.03M | -37.15%231.5K | -48.66%248.34K | -45.47%222.99K |
| Selling and administrative expenses | -49.17%43.12K | -34.44%278.83K | 32.20%106K | -72.63%22.99K | 0.13%78.5K | -54.36%84.84K | -59.63%425.32K | -54.25%80.18K | -76.13%84K | -70.54%78.4K |
| -Selling and marketing expense | --300 | 148.04%4.8K | 95.92%3.79K | --300 | --708 | --0 | --1.93K | --1.93K | --0 | --0 |
| -General and administrative expense | -49.53%42.82K | -35.28%274.03K | 30.63%102.21K | -72.99%22.69K | -0.78%77.79K | -54.36%84.84K | -59.82%423.39K | -55.35%78.24K | -76.13%84K | -70.54%78.4K |
| Depreciation amortization depletion | -99.80%283 | -2.97%547.42K | -2.44%135.92K | -4.04%135.92K | -2.99%137.42K | -2.40%138.16K | 5.14%564.17K | -14.07%139.32K | 13.47%141.64K | 13.47%141.65K |
| -Depreciation and amortization | -99.80%283 | -2.97%547.42K | -2.44%135.92K | -4.04%135.92K | -2.99%137.42K | -2.40%138.16K | 5.14%564.17K | -14.07%139.32K | 13.47%141.64K | 13.47%141.65K |
| Other operating expenses | -13.75%3.91K | 38.81%57.91K | 136.44%28.38K | -66.83%7.53K | 34.37%3.96K | 399.23%4.54K | -35.49%41.72K | -61.21%12K | 223.05%22.69K | -83.63%2.95K |
| Operating profit | 79.15%-47.26K | 14.58%-880.89K | -16.76%-270.3K | 33.89%-164.19K | 1.48%-219.69K | 30.96%-226.72K | 37.69%-1.03M | 37.15%-231.5K | 48.66%-248.34K | 45.47%-222.99K |
| Net non-operating interest income expense | -219.81%-23.86K | -333.29%-51.93K | -484.71%-25.58K | -149.75%-10.05K | -254.94%-8.84K | -580.75%-7.46K | -482.64%-11.99K | -100.50%-4.38K | -774.78%-4.02K | -1,437.04%-2.49K |
| Non-operating interest income | -74.81%33 | 139.19%354 | 61.11%58 | 0.00%37 | 392.31%128 | 167.35%131 | -89.81%148 | -60.00%36 | -75.50%37 | -91.72%26 |
| Non-operating interest expense | 214.73%23.89K | 374.35%50.98K | 704.40%24.33K | 148.39%10.09K | 256.36%8.97K | 563.06%7.59K | 206.27%10.75K | 33.14%3.03K | 564.65%4.06K | 428.57%2.52K |
| Total other finance cost | ---- | -5.77%1.31K | ---- | ---- | ---- | ---- | --1.39K | ---- | ---- | ---- |
| Other net income (expense) | 68.94%12.07K | -11,143.79%-3.46M | -17,496.17%-3.47M | 10.14K | -170.14%-5.49K | 179.19%7.14K | -788.66%-30.8K | -1,116.79%-19.75K | -129.79%-2.03K | |
| Gain on sale of security | 68.94%12.07K | 80.92%-5.88K | 10.54%-17.67K | --10.14K | -170.14%-5.49K | 179.19%7.14K | -788.66%-30.8K | -1,116.79%-19.75K | ---- | -129.79%-2.03K |
| Special income (charges) | ---- | ---3.46M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| -Less:Impairment of capital assets | ---- | --3.46M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Income before tax | 73.99%-59.06K | -309.27%-4.4M | -1,374.99%-3.77M | 34.97%-164.1K | -2.86%-234.02K | 32.93%-227.04K | 35.01%-1.07M | 30.64%-255.62K | 48.33%-252.36K | 43.44%-227.52K |
| Income tax | ||||||||||
| Net income | 73.99%-59.06K | -309.27%-4.4M | -1,374.99%-3.77M | 34.97%-164.1K | -2.86%-234.02K | 32.93%-227.04K | 35.01%-1.07M | 30.64%-255.62K | 48.33%-252.36K | 43.44%-227.52K |
| Net income continuous Operations | 73.99%-59.06K | -309.27%-4.4M | -1,374.99%-3.77M | 34.97%-164.1K | -2.86%-234.02K | 32.93%-227.04K | 35.01%-1.07M | 30.64%-255.62K | 48.33%-252.36K | 43.44%-227.52K |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 73.99%-59.06K | -309.27%-4.4M | -1,374.99%-3.77M | 34.97%-164.1K | -2.86%-234.02K | 32.93%-227.04K | 35.01%-1.07M | 30.64%-255.62K | 48.33%-252.36K | 43.44%-227.52K |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 73.99%-59.06K | -309.27%-4.4M | -1,374.99%-3.77M | 34.97%-164.1K | -2.86%-234.02K | 32.93%-227.04K | 35.01%-1.07M | 30.64%-255.62K | 48.33%-252.36K | 43.44%-227.52K |
| Basic earnings per share | 74.00%-0.001 | -250.00%-0.07 | -500.00%-0.06 | 34.97%-0.0028 | -2.84%-0.004 | 61.66%-0.0038 | 33.33%-0.02 | 0.00%-0.01 | 57.39%-0.0043 | 61.58%-0.0038 |
| Diluted earnings per share | 74.00%-0.001 | -250.00%-0.07 | -500.00%-0.06 | 34.97%-0.0028 | -2.84%-0.004 | 61.66%-0.0038 | 33.33%-0.02 | 0.00%-0.01 | 57.39%-0.0043 | 61.58%-0.0038 |
| Dividend per share | ||||||||||
| Currency Unit | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg